TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program
- Conditions
- First Posted Date
- 2007-12-07
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 2585
- Registration Number
- NCT00569491
- Locations
- 🇺🇸
Advanced Cardiac Specialists, Gilbert, Arizona, United States
🇺🇸Cardiology Associates of NEA, Jonesboro, Arkansas, United States
🇺🇸Salinas Valley Memorial Hospital, Salinas, California, United States
TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program
- Conditions
- First Posted Date
- 2007-12-07
- Last Posted Date
- 2008-09-29
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 5016
- Registration Number
- NCT00569751
- Locations
- 🇺🇸
Bakersfield Memorial Hospital, Bakersfield, California, United States
🇺🇸Krannert Institute of Cardiology, Indianapolis, Indiana, United States
🇺🇸Bethesda North Hospital, Cincinnati, Ohio, United States
A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation
- Conditions
- Interventions
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT00528021
- Locations
- 🇺🇸
Global Health Associates of Miami Inc, Florida City, Florida, United States
TheraSphere for the Treatment of Liver Metastases
- Conditions
- Interventions
- First Posted Date
- 2007-08-06
- Last Posted Date
- 2021-05-13
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 151
- Registration Number
- NCT00511862
- Locations
- 🇺🇸
John Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Northwestern Memorial Hospital, Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸Albany Medical Center, Albany, New York, United States
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
- Conditions
- Interventions
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT00510627
- Locations
- 🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸New York University, New York, New York, United States
Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System
- Conditions
- Interventions
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 28
- Registration Number
- NCT00497367
- Locations
- 🇫🇷
Institut Hospitalier Jacques Cartier-ICPS, 6, Avenue du Noyer Lambert, Massy, France
🇳🇿Mercy Angiography Unit, 98 Mountain Road, First Floor, Auckland, Epsom, New Zealand
🇩🇪HELIOS Klinikum Siegburg, Ringstrasse 49, Siegburg, Germany
TAXUS PERSEUS Small Vessel
- Conditions
- Interventions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2014-05-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 224
- Registration Number
- NCT00489541
- Locations
- 🇺🇸
Bakersfield Memorial Hospital, Bakersfield, California, United States
🇺🇸Sarasota Memorial Hospital, Sarasota, Florida, United States
🇺🇸LeBauer Cardiovascular Research Foundation, Greensboro, North Carolina, United States
Spinal Cord Stimulation for Painful Diabetic Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2007-06-19
- Last Posted Date
- 2012-03-13
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1
- Registration Number
- NCT00487981
- Locations
- 🇺🇸
Deaconess Pain Management Center, Evansville, Indiana, United States
TAXUS PERSEUS Workhorse
- First Posted Date
- 2007-06-08
- Last Posted Date
- 2014-05-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1264
- Registration Number
- NCT00484315
- Locations
- 🇺🇸
University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸Tallahassee Memorial Hospital, Tallahassee, Florida, United States
🇺🇸Mediquest Research at Munroe Regional Medical Center, Ocala, Florida, United States
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
- Conditions
- Interventions
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2022-06-22
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 4
- Registration Number
- NCT00479765
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸The Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸The University of Chicago Brain Tumor Center, Chicago, Illinois, United States